Arvinas Number Of Shares Shorted vs. Revenue

ARVN Stock  USD 18.48  0.65  3.65%   
Based on Arvinas' profitability indicators, Arvinas may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Arvinas' ability to earn profits and add value for shareholders.
For Arvinas profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Arvinas to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Arvinas utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Arvinas's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Arvinas over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Arvinas Revenue vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Arvinas's current stock value. Our valuation model uses many indicators to compare Arvinas value to that of its competitors to determine the firm's financial worth.
Arvinas is rated fifth in number of shares shorted category among its peers. It is rated third in revenue category among its peers totaling about  8.70  of Revenue per Number Of Shares Shorted. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arvinas' earnings, one of the primary drivers of an investment's value.

Arvinas Revenue vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Arvinas

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
9.02 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Arvinas

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
78.5 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Arvinas Revenue vs Competition

Arvinas is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 778.63 Million. Arvinas retains roughly 78.5 Million in revenue claiming about 10% of equities under Health Care industry.

Arvinas Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Arvinas, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Arvinas will eventually generate negative long term returns. The profitability progress is the general direction of Arvinas' change in net profit over the period of time. It can combine multiple indicators of Arvinas, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.

Arvinas Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Arvinas. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Arvinas position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Arvinas' important profitability drivers and their relationship over time.

Use Arvinas in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.

Arvinas Pair Trading

Arvinas Pair Trading Analysis

The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.
The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Arvinas position

In addition to having Arvinas in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Staples ETFs Thematic Idea Now

Consumer Staples ETFs
Consumer Staples ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:
Check out Trending Equities.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
To fully project Arvinas' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Arvinas at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Arvinas' income statement, its balance sheet, and the statement of cash flows.
Potential Arvinas investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Arvinas investors may work on each financial statement separately, they are all related. The changes in Arvinas's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arvinas's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.